Veste

Not upheld: Service failures generally complaint against Medicash Health Benefits Limited

Financial Ombudsman decision DRN-6307455 of 2026-06-25T00:00:00+00:00. Service failures generally complaint against Medicash Health Benefits Limited. Outcome: Not upheld.

Decision detail

ReferenceDRN-6307455
Decision date2026-06-25T00:00:00+00:00
FirmMedicash Health Benefits Limited
ProductOther regulated product
Claim typeService failures generally
OutcomeNot upheld
RemedyNo remedy ordered. The complaint was not upheld.

Summary

Mr and Mrs G complained that Medicash Health Benefits Limited refused to continue their 'Active Dual Bronze Plus' healthcare cash plan after Mr G left his employment. The policy was contractually linked to Mr G's employer and could not continue outside that arrangement. Although Mr and Mrs G requested to amend payment details and continue the policy, Medicash informed them it would end and offered an alternative essentials plan instead. The ombudsman found Medicash acted fairly as the policy terms were employment-linked, the firm properly communicated the cancellation, and offered alternative cover. The complaint was not upheld.

The Ombudsman's reasoning

The policy was contractually linked to Mr G's employment and could not continue once that employment ended. Medicash fairly communicated this to Mr and Mrs G and offered an alternative level of cover. While Medicash operates a community underwriting model without risk-rated premiums, it may review claims history when considering new applications or continuation outside company-linked arrangements to ensure scheme sustainability. The ombudsman found no evidence of unfair treatment compared to others in similar circumstances. Although 28 days' notice may not have been formally given, the policy would have been cancelled around the same time anyway given the employment termination date.

How this compares

GroupDecisionsUphold rate
Medicash Health Benefits Limited, all decisions2038%
Service failures generally, all decisions34,19332%
Other regulated product, all decisions47,44930%

Source

Read the original decision on the Financial Ombudsman Service website